Abstract
Alzheimer's disease(AD) and Parkinson's disease(PD) are the two most common neurodegenerative diseases of the aged, and the pathogenesis and treatment are the hot spots in the current study.With the advance of high-throughput sequencing technology and the decline of cost, RNA sequencing (RNA-Seq) has also become a powerful method for the neurodegenerative disease mechanism research and biomarker discovery. Compared with microarray,RNA-Seq has the advantages of high sensitivity, high accuracy, high repeatability and low noise, and has a wider application in the study of AD and PD, including detection of differentially expressed genes, alternative splicing, new lncRNA predictive analysis and miRNAs regulation. Influenced by the pathological complexity and specimens,the regulatory mechanism research of AD and PD is not deep enough,and we also face great challenge in clinical diagnosis and treatment application. But with the development of new technologies and methods, RNA-Seq will further promote the research and clinical transformation of neurodegenerative diseases. Key words: Alzheimer's disease; Parkinson's disease; neurodegenerative diseases; RNA-Seq; alternative splicing; lncRNA; miRNA
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
